Umar Mian

Dr. Umar Mian

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2022 in Clinical Ophthalmology
Verified
Journal Article
Open access
PDF file
HMHasan Muqri
Hasan Muqri
ASAnurag Shrivastava
Anurag Shrivastava
RMRakin Muhtadi
Rakin Muhtadi
RCRoy S Chuck
Roy S Chuck
UMUmar Mian
Umar Mian
Background: A telemedicine screening initiative was implemented by the Montefiore Health System to improve access to eyecare for a multi-ethnic, at-risk population of diabetic patients in a largely underserved urban community in the Bronx, New York. This retrospective, cross-sectional analysis evaluates the societal benefit and financial sustainability of this program by analyzing both cost and revenue generation based on current standard Medicare reimbursement rates. Methods: Non-mydriatic fundus cameras were placed in collaboration with a vendor in eight outpatient primary care sites throughout the Montefiore Health Care System, and data was collected between June 2014 and July 2016. Fundus photos were electronically transmitted to a central reading center to be systematically reviewed and coded by faculty ophthalmologists, and patients were subsequently scheduled for ophthalmic evaluation based upon a predetermined treatment algorithm. A retrospective chart review of 2251 patients was performed utilizing our electronic medical record system (Epic Systems, Verona WI). Revenue was projected utilizing standard Medicare rates for our region while societal benefit was calculated using quality adjusted life years (QALY). Results: Of the 2251 patient charts reviewed, 791 patients (35.1%) were seen by Montefiore ophthalmologists within a year of the original screening date. Estimated revenue generated by these visits was $276,800, with the majority from the treatment of retinal disease ($208,535), and the remainder from other ophthalmic conditions detected in the fundus photos ($68,265). There was a societal benefit of 14.66 quality adjusted life years (QALYs) with an estimated value of $35,471/QALY. Conclusion: This telemedicine initiative was successful in identifying many patients with diabetic retinopathy and other ophthalmic conditions who may otherwise not have been formally evaluated. Our analysis demonstrates the program to generate a downstream revenue of nearly $280K with a cost benefit below < 50% of the threshold of $100,000/QALY, and therefore cost-effective in marginalized communities.

28 January 2013 in Journal of Ophthalmic Inflammation and Infection
Verified
Journal Article
Open access
PDF file
AHAlbert Hazan
Albert Hazan
RPRakesh M Patel
Rakesh M Patel
DLDavid Levinson
David Levinson
UMUmar Mian
Umar Mian
DGDavid C Gritz
David C Gritz
Background: Toxoplasma retinochoroiditis can have an atypical presentation and be difficult to diagnose in immunocompromised patients. Accurate diagnosis and appropriate treatment is important since the disease can be aggressive in these patients. This paper is a case report with literature review, emphasizing on the diagnosis and treatment of Toxoplasma retinochoroiditis. Findings: A 27-year-old male with chronic myelogenous leukemia with history of bone marrow transplantation presented with floaters in his right eye. Fundus exam showed bilateral, multifocal retinochoroiditis with subsequent development of a mild vitritis. Serum cytomegalovirus and toxoplasmosis antibody titers and syphilis screen were negative. Aqueous polymerase chain reaction (PCR) analysis revealed the presence of Toxoplasma gondii DNA OU. Clindamycin (1.0 mg/0.1 mL) was injected bilateral intravitreal OU twice at 4 days apart with subsequent resolution of retinochoroiditis. Conclusions: When evaluating retinochoroiditis in an immunocompromised patient, one must keep a high index of suspicion for atypical presentations of well-known disease entities. Aqueous and vitreous samples for PCR can be useful in obtaining an accurate diagnosis and therefore provide appropriate management for the patient. Intravitreal clindamycin is an option for treatment in these patients.

1 June 2010 in Archives of Ophthalmology (1950)
Verified
Journal Article
Open access
PDF file
PBPriti Batta
Priti Batta
HEHarry M. Engel
Harry M. Engel
ASAnurag Shrivastava
Anurag Shrivastava
KFKatherine Freeman
Katherine Freeman
UMUmar Mian
Umar Mian
The diagnosis of glaucoma is generally established by detecting characteristic visual field defects in association with visible alterations in the surface contour of the optic nerve and elevation of the intraocular pressure. A substantial minority of retinal ganglion cells may be lost before a change in appearance of the optic disc can be discerned.1 High-resolution retinal images obtained by optical coherence tomography (OCT) can be used to quantitatively assess retinal nerve fiber layer (RNFL) thickness.2-4 Because thinning of the RNFL precedes ophthalmoscopically visible alteration in the cup-disc ratio, OCT has the potential to support a diagnosis of glaucoma at an early stage.5-8

BMBrian Morris
Brian Morris
JTJenna Tauber
Jenna Tauber
ARAnvit Rai
Anvit Rai
CTCassandra Thiel
Cassandra Thiel
TGTiana Jamie Geringer
Tiana Jamie Geringer
UMUmar Mian
Umar Mian
(1) Background: Healthcare is a major contributor to global greenhouse gas (GHG) emissions, especially within the surgical suite. Ophthalmologists play a role, since they frequently perform high-volume procedures, such as cataract surgery. This review aims to summarize the current literature on surgical waste and GHG emissions in ophthalmology and proposes a framework to standardize future studies. (2) Methods: Protocol and reporting methods were based on PRISMA guidelines for scoping reviews. Articles that reported any quantitative measurement of waste or GHGs produced from ophthalmic surgeries were eligible for inclusion. Commentaries, opinion papers, reviews and articles in a non-English language were excluded. (3) Results: A total of 713 articles were reviewed, with 10 articles found to meet inclusion criteria. Six studies produced level 3 evidence, two level 4 evidence, and one level 5 evidence. According to studies, most of the GHGs came from procurement of surgical materials, followed by travel emissions and building energy. (4) Conclusions: Research on waste and GHGs produced in ophthalmic surgery is limited, and existing studies utilize varied approaches to quantify this waste. We propose a standardized waste-lifecycle framework for researchers to organize future research. Such standardization will help in comparing studies and may uncover more opportunities to implement impactful waste reduction strategies in ophthalmology.

PZPatricia Zulueta
Patricia Zulueta
CMcaterina minniti
caterina minniti
ARAnvit Rai
Anvit Rai
TGTiana Jamie Geringer
Tiana Jamie Geringer
JMJee-Young Moon
Jee-Young Moon
UMUmar Mian
Umar Mian
The American Academy of Ophthalmology and the National Heart, Lung and Blood Institute recommend patients with sickle cell disease (SCD) undergo dilated funduscopic exams (DFE) every 1–2 years to screen for sickle retinopathy. There is a paucity of data on the adherence rate to these guidelines; a retrospective study was performed to evaluate our institution’s adherence. A chart review of 842 adults with SCD, seen 3/2017–3/2021 in the Montefiore healthcare system (All Patients), was done. Only about half of All Patients (n = 842) had >1 DFE during the study period (Total Examined Patients, n = 415). The Total Examined Patients were categorized as screening, those without retinopathy (Retinopathy−, n = 199), or follow-up, including individuals previously diagnosed with retinopathy (Retinopathy+, n = 216). Only 40.3% of screening patients (n = 87) had DFE at least biennially. As expected, there was a significant decrease in the average DFE rate of the Total Examined Patients after the COVID-19 pandemic started (13.6%) compared to pre-COVID (29.8%, p < 0.001). Similarly, there was a significant decrease in the screening rate of Retinopathy− patients from 18.6% on average pre-COVID to 6.7% during COVID (p < 0.001). This data shows the sickle retinopathy screening rate is low and innovative approaches may need to be employed to remedy this issue.

14 February 2014 in Ophthalmic Surgery, Lasers and Imaging Retina
Verified
Journal Article
Closed access
PDF file
ITIrena Tsui
Irena Tsui
EEEdward Ebani
Edward Ebani
JRJamie B. Rosenberg
Jamie B. Rosenberg
RARobert M. Angert
Robert M. Angert
JLJuan Lin
Juan Lin
UMUmar Mian
Umar Mian
BACKGROUND AND OBJECTIVE: Retinopathy of prematurity presents differently in developing versus developed countries, which may be due to environmental as well as racial differences. PATIENTS AND METHODS: Retrospective chart review of infants screened for ROP at a single neonatal intensive care unit. Risk factors were reviewed. Main outcome measures were rates of plus disease or treatment-requiring ROP by race. RESULTS: The study included 497 infants screened for ROP in an urban neonatal intensive care unit. Gestational age, birth weight, and bronchopulmonary dysplasia were independent risk factors for both plus disease and treatment-requiring ROP with type 3 multivariate analysis. Self-identified white race was also a risk factor for plus disease and treatment-requiring ROP. Race was significantly associated with maternal age, multiple births, and blood transfusions. CONCLUSION: In the study population, white race was an independent risk factor for plus disease and ROP treatment. [ Ophthalmic Surg Lasers Imaging Retina . 2014;45:138–142.]